Terms: = Colorectal cancer AND THRAP3, MGC133082, 9967, ENSG00000054118, FLJ22082, TRAP150, MGC133083, Q9Y2W1
3 results:
1. Deciphering the Clinical Significance and Kinase Functions of GSK3α in Colon cancer by Proteomics and Phosphoproteomics.
Gao L; Lu Y; Chen HN; Li Z; Hu M; Zhang R; Wang X; Xu Z; Gong Y; Wang R; Du D; Hai S; Li S; Su D; Li Y; Xu H; Zhou ZG; Dai L
Mol Cell Proteomics; 2023 May; 22(5):100545. PubMed ID: 37031867
[TBL] [Abstract] [Full Text] [Related]
2. Nuclear PD-L1 promotes cell cycle progression of BRAF-mutated colorectal cancer by inhibiting thrap3.
Ma R; Liu Y; Che X; Li C; Wen T; Hou K; Qu X
Cancer Lett; 2022 Feb; 527():127-139. PubMed ID: 34923044
[TBL] [Abstract] [Full Text] [Related]
3. Production of monoclonal antibodies recognising the peptide core of MUC2 intestinal mucin.
Durrant LG; Jacobs E; Price MR
Eur J Cancer; 1994; 30A(3):355-63. PubMed ID: 8204359
[TBL] [Abstract] [Full Text] [Related]
